V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
Tech — Software

Certara Executive Compensation (FY25)

CERT · Radnor, PA · Executive and director compensation, fiscal 2022 to 2025
Data as of September 7, 2026Latest filing (8-K): May 15, 2026
213 figures on this page: 209 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
Latest say-on-pay support
=
May 14, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — William Feehery: $7,219,615 → $6,491,387 (10.1% lower)
Say-on-pay support: 95.3% → 98.0% (2.7 points higher)
CEO pay ratio: 50:1 → 67:1 (34.0% higher)

Frequently asked questions

Answers drawn from the data on this page.
What was Certara's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 98.0% of votes cast including abstentions in favor at the meeting held May 14, 2026.
Which companies are in Certara's peer group?
The disclosed peer group names AbCellera Biologics Inc., Accolade, Inc., Alkermes plc, Altair Engineering Inc. and Domo, Inc., among others.
What is Certara's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 67:1, against median employee compensation of $96,682.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Feehery
Chief Executive Officer
◇—◇—◇—◇◇
M. Andrew Schemick
Chief Financial Officer
◇—◇—◇—◇◇
Leif Pedersen
President, Software
◇—◇—◇—◇◇
Patrick Smith
President, Integrated Drug Development
◇—◇—◇—◇◇
Robert Aspbury
President, Simcyp
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Feehery
Chief Executive Officer
◇—◇—◇—◇◇
John Gallagher III
Senior Vice President and CFO
◇◇◇—◇—◇◇
Patrick Smith
President, Certara Drug Development Solutions
◇—◇—◇—◇◇
Leif Pedersen
President, Chief Commercial Officer
◇—◇—◇—◇◇
Robert Aspbury
President, Certara Scientific Software
◇—◇—◇—◇◇
M. Andrew Schemick
Former CFO
Departed during or after this year
◇—————◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Feehery
Chief Executive Officer
◇—◇—◇—◇◇
John Gallagher III
SVP and CFO
◇—◇—◇—◇◇
Leif Pedersen
President, Chief Commercial Officer
◇—◇—◇—◇◇
Patrick Smith
President, Certara Drug Development Solutions
◇—◇—◇—◇◇
Robert Aspbury
President, Certara Predictive Technologies
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
William Feehery
Former Chief Executive Officer
Departed during or after this year
◇—◇—◇—◇◇
John Gallagher III
Senior Vice President and Chief Financial Officer
◇—◇—◇—◇◇
Robert Aspbury
President, Certara Predictive Technologies
◇—◇—◇—◇◇
Leif Pedersen
President, Chief Commercial Officer
◇—◇—◇—◇◇
Adrian McKemey
President, Certara Drug Development Solutions
◇◇◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Adrian McKemeyRSU◇——◇——◇
Adrian McKemeyPSU◇◇◇—◇—◇
J. Gallagher IIIPSU◇◇◇—◇—◇
J. Gallagher IIIRSU◇——◇——◇
Leif PedersenRSU◇——◇——◇
Leif PedersenPSU◇◇◇—◇—◇
Robert AspburyPSU◇◇◇—◇—◇
Robert AspburyRSU◇——◇——◇
William FeeheryPSU◇◇◇—◇—◇
William FeeheryRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
John Gallagher IIIRSU◇◇——
PSU◇◇——
Robert AspburyPSU◇◇——
RSU◇◇——
William FeeheryPSU◇◇——
Leif PedersenPSU◇◇——
RSU◇◇——
Adrian McKemeyRSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
James Cashman III
Board chair
◇◇————◇
Eran Broshy
◇◇————◇
Nancy Killefer
◇◇————◇
Matthew Walsh
◇◇————◇
Cynthia Collins
◇◇————◇
John Reynders
◇◇————◇
Rosemary Crane
◇◇————◇
David Spaight, Stephen McLean, Jon Resnick and Arjun Bedi served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • AbCellera Biologics Inc. ABCL
  • Accolade, Inc. ACCD
  • Alkermes plc ALKS
  • Altair Engineering Inc. ALTR
  • Domo, Inc. DOMO
  • Health Catalyst, Inc. HCAT
  • HealthEquity, Inc. HQY
  • HealthStream, Inc. HSTM
  • Medpace Holdings, Inc. MEDP
  • Model N, Inc. MODN
  • Omnicell, Inc. OMCL
  • Qualys, Inc. QLYS
  • Repligen Corporation RGEN
  • Schrödinger, Inc. SDGR
  • SPS Commerce, Inc. SPSC
  • TruBridge, Inc. symbol not shown

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 14, 2026=◇◇◇
2024May 21, 2025=◇◇◇
2023May 21, 2024=◇◇◇
2022May 23, 2023=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Certara files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Certara disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Certara sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Certara's disclosed peer group is defensible, who names Certara back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
213 figures on this page: 209 cited to the filing that reported them, 4 calculated from figures it prints.
209 cited to the filing
4 calculated from the filing

Documents cited

  1. 0001104659-26-062640
  2. 0001104659-26-039372
    CEO Pay Ratio · DIRECTOR COMPENSATION · Director Compensation Table · Grants of Plan-Based Awards · and 2 more sections
  3. 0001104659-25-052027
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001104659-25-032816
    SUMMARY COMPENSATION TABLE
  5. 0001827090-24-000018
  6. 0001104659-24-045501
    SUMMARY COMPENSATION TABLE
  7. 0001558370-23-010467
  8. 0001104659-23-043233
    SUMMARY COMPENSATION TABLE
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Certara executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/CERT (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Certara and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Tech — Software rankings

Chief executive pay — Tech — SoftwareCEO pay ratio — Tech — SoftwareSay-on-pay support — Tech — Software

Peers Certara discloses

The companies named in CERT's own disclosed peer group.

AbCellera Biologics Inc.Alkermes plcHealth Catalyst, Inc.HealthStream, Inc.Medpace Holdings, Inc.Qualys, Inc.Repligen CorporationSchrödinger, Inc.SPS Commerce, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy